BIO lobbying event
Executive Summary
Biotechnology Industry Organization brings together about 175 executives from its member companies to lobby on Capitol Hill April 8 and 9. The group said topics covered in members' Congressional visits included a Medicare prescription drug benefit, "regulatory concerns" with generic biologics, and changing Medicare's current Outpatient Prospective Payment System for coverage of hospital-administered drugs and biologics (1"The Pink Sheet" March 17, p. 22)...